» Articles » PMID: 24384906

AAV Empty Capsids: for Better or for Worse?

Overview
Journal Mol Ther
Publisher Cell Press
Date 2014 Jan 4
PMID 24384906
Citations 32
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Novel Method for Separating Full and Empty Adeno-Associated Viral Capsids Using Ultrafiltration.

Sarmah D, Husson S Membranes (Basel). 2024; 14(9).

PMID: 39330535 PMC: 11434191. DOI: 10.3390/membranes14090194.


Analytical characterization of full, intermediate, and empty AAV capsids.

McColl-Carboni A, Dollive S, Laughlin S, Lushi R, MacArthur M, Zhou S Gene Ther. 2024; 31(5-6):285-294.

PMID: 38374348 PMC: 11090809. DOI: 10.1038/s41434-024-00444-2.


A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies.

Pan Y, Rohde M, Zeitler J, Namburi S, Cao L, Hu J Mol Ther Methods Clin Dev. 2023; 31:101126.

PMID: 37920239 PMC: 10618111. DOI: 10.1016/j.omtm.2023.101126.


PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain.

Ajenjo J, Seo J, Foiret J, Wu B, Raie M, Wang J Theranostics. 2023; 13(15):5151-5169.

PMID: 37908737 PMC: 10614693. DOI: 10.7150/thno.85549.


Bioengineered Hybrid Rep 2/6 Gene Improves Encapsulation of a Single-Stranded Expression Cassette into AAV6 Vectors.

Tejero M, Duzenli O, Caine C, Kuoch H, Aslanidi G Genes (Basel). 2023; 14(10).

PMID: 37895215 PMC: 10606878. DOI: 10.3390/genes14101866.


References
1.
Mingozzi F, Anguela X, Pavani G, Chen Y, Davidson R, Hui D . Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med. 2013; 5(194):194ra92. PMC: 4095828. DOI: 10.1126/scitranslmed.3005795. View

2.
Gao K, Li M, Zhong L, Su Q, Li J, Li S . Empty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-Effects. Mol Ther Methods Clin Dev. 2014; 1(9):20139. PMC: 4255953. DOI: 10.1038/mtm.2013.9. View

3.
Allay J, Sleep S, Long S, Tillman D, Clark R, Carney G . Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial. Hum Gene Ther. 2011; 22(5):595-604. PMC: 3081439. DOI: 10.1089/hum.2010.202. View

4.
Nathwani A, Tuddenham E, Rangarajan S, Rosales C, McIntosh J, Linch D . Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med. 2011; 365(25):2357-65. PMC: 3265081. DOI: 10.1056/NEJMoa1108046. View

5.
Hoffman B, Herzog R . Covert warfare against the immune system: decoy capsids, stealth genomes, and suppressors. Mol Ther. 2013; 21(9):1648-50. PMC: 3776640. DOI: 10.1038/mt.2013.176. View